Beredaki MI, Arendrup MC, Andes D, Meletiadis J, et al. Development of an in vitro pharmacokinetic/pharmacodynamic model in the presence of serum for studying micafungin activity against Candida albicans: a need for revision of CLSI susceptibility breakpoints. J Antimicrob Chemother 2023 Apr 18:dkad096. doi: 10.1093.
PMID: 37071557